Clinical Trial Spotlight_ Determining Efficacy of Immunotherapy in Stage III Lung Cancer [360p]
Dr. Ben Levy discusses two trials that are trying to determine if Immunotherapy can help lung cancer patients with earlier stage disease. Click here for information about the PACIFIC trial. The lung c...
Author: cancergrace
Added: 04/03/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 3, 2019 Category: Cancer & Oncology Source Type: podcasts
Clinical Trials of Immune Checkpoint Inhibitors as First Line Therapy for Advanced NSCLC [360p]
Dr. Jack West summarizes the rationale for testing immune checkpoint inhibitors as a first line treatment for patients with advanced NSCLC and highlights details of two trials testing this question.
Author: cancergrace
Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts
Options for EGFR Mutation-Positive Patients with T790M Mutation-Negative Acquired Resistance [360p]
Dr. Jack West reviews treatment options for patients with an EGFR activating mutation and acquired resistance but no T790M mutation, focusing on a clinical trial with the novel hypoxia-induced pan-HER...
Author: cancergrace
Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts
Clinical Trial Spotlight_ Identifying Lung Cancer Patients Who Respond to Ponatinib [360p]
Dr. Ross Camidge discusses a clinical trial studying patients with advanced stage lung cancer to identify those who may respond to a drug called ponatinib. Both small cell and non small cell lung canc...
Author: cancergrace
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
Clinical Trial Spotlight_ Can Epigenetic Priming Improve Efficacy of Immunotherapy in NSCLC_ [360p]
Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve outcomes in patients who receive immunotherapy for advanced lung cancer.
Author: cancergrace
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
Clinical Trial Spotlight_ Targeting Brain Mets in EGFR Lung Cancer Patients [360p]
Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is...
Author: cancergrace
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
The Lung Cancer Master Protocol_SWOG 1400 as a Clinical Trial for a New Era of Molecular Oncology [360p]
Dr. Jack West reviews the Lung Cancer Master Protocol for second line treatment of patients with advanced squamous NSCLC, an "umbrella protocol" in which all patients undergo molecular testing and hav...
Author: cancergrace
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
Robert Dreicer, MD, MS, MACP, FASCO - Unraveling the Complexities of Prostate Cancer Management: Focus on Therapeutic Decisions for Early-Stage Disease and the Implications for Later-Stage Disease
Go online to PeerView.com/XHP860 to view the entire program with slides. In this activity, experts in the management of patients with prostate cancer discuss recent advances that have rapidly expanded the therapeutic landscape, including treatments for both early-stage and advanced disease. Focusing on selection and sequencing of therapies based on patient and tumor characteristics, prior treatment history, and patient preferences, the expert panel provides an engaging MasterClass and Practicum that combines key clinical evidence and current guideline recommendations with practical guidance for personalizing application of...
Source: PeerView CME/CE Audio Podcast - Oncology - March 29, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
David F. McDermott, MD - Making Effective Therapeutic Choices for Advanced RCC in an Evolving Treatment Landscape: Personal Insights From the Patient CaseBook
Go online to PeerView.com/FEJ860 to view the entire program with slides. In this activity, based on a recent live symposium held at the 2019 Genitourinary Cancers Symposium in San Francisco, experts in renal cell carcinoma (RCC) dip into their patient “CaseBook” to offer insights from their own practice on how best to bridge the divide between clinical research and daily care in the management of RCC. Pairing analysis of the latest evidence with application of key clinical concepts to decision-making in a complex therapeutic landscape, the expert panel explores how best to leverage the potency of newer agents across di...
Source: PeerView CME/CE Audio Podcast - Oncology - March 27, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Multiple Myeloma: A Pathway to Better Outcomes
Earn CME credit for this activity: <a target='_blank' href='https://www.naccme.com/program/2018-802-05'>https://www.naccme.com/prog...</a><br /><br />This on-demand webcast examines recent clinical trial data for novel and emerging therapies, including doublet and trip...
Author: imedex
Added: 03/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 6, 2019 Category: Cancer & Oncology Source Type: podcasts
FDA Drug Safety Podcast: Safety trial finds risk of blood clots in the lungs and death with higher dose of tofacitinib (Xeljanz, Xeljanz XR) in rheumatoid arthritis patients; FDA to investigate
On February 25, 2019 FDA alerted the public that a safety clinical trial found an increased risk of blood clots in the lungs and death when a 10 mg twice daily dose of tofacitinib (brand names Xeljanz, Xeljanz XR) was used in patients with rheumatoid arthritis (or RA). (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 5, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Edward S. Kim, MD, FACP - Beyond Clinical Trials: Can Real-World Evidence Provide a Roadmap for Long-Term Treatment Planning in EGFRMutation-Positive NSCLC?
Beyond Clinical Trials: Can Real-World Evidence Provide a Roadmap for Long-Term Treatment Planning in EGFRMutation-Positive NSCLC? (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - February 27, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
JAMA Oncology : Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non –Small Cell Lung Cancer
Interview with David A. Palma, MD, PhD, author of Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 21, 2019 Category: General Medicine Source Type: podcasts
